Who owns Corbus Pharmaceuticals Holdings, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRBP from SEC Form 13F filings across 120 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 120 institutions disclosed 17.6M shares of Corbus Pharmaceuticals Holdings, Inc. worth $120.2M — about 84.6% of shares outstanding; the largest disclosed holder is Cormorant Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
120
13F holders
$120.2M
value, 2026 filers
84.6%
of shares outstanding (17.6M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CRBP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 2.3M | $16.0M | 1.1% | 11.3% | 0.0% |
| 2 | RA CAPITAL MANAGEMENT, L.P.NEW | 1.9M | $13.1M | 0.1% | 9.2% | new |
| 3 | BlackRock, Inc. | 1.7M | $11.9M | 0.0% | 8.4% | +31.5% |
| 4 | MPM BIOIMPACT LLCNEW | 1.7M | $11.4M | 0.8% | 8% | new |
| 5 | ORBIMED ADVISORS LLC | 1.7M | $11.4M | 0.2% | 8% | -4.1% |
| 6 | Jones Hill Capital LP | 886,428 | $6.0M | 1.0% | 4.3% | +35.6% |
| 7 | Sio Capital Management, LLCNEW | 766,364 | $5.2M | 1.0% | 3.7% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 750,276 | $5.1M | 0.0% | 3.6% | -1.4% |
| 9 | Caption Management, LLC | 474,599 | $3.2M | 0.0% | 2.3% | +1604.0% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 450,729 | $3.1M | 0.0% | 2.2% | +6.5% |
| 11 | AQR CAPITAL MANAGEMENT LLCNEW | 335,051 | $2.3M | 0.0% | 1.6% | new |
| 12 | MARSHALL WACE, LLP | 308,138 | $2.1M | 0.0% | 1.5% | +288.4% |
| 13 | STATE STREET CORP | 261,626 | $1.8M | 0.0% | 1.3% | +2.7% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 210,313 | $1.4M | 0.0% | 1% | +10.6% |
| 15 | ADAR1 Capital Management, LLC | 195,469 | $1.3M | 0.1% | 0.9% | -53.7% |
| 16 | Exome Asset Management LLC | 190,714 | $1.3M | 0.8% | 0.9% | +3.1% |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 183,420 | $1.3M | 0.0% | 0.9% | -37.4% |
| 18 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 181,102 | $1.2M | 0.0% | 0.9% | +19.4% |
| 19 | Prosight Management, LP | 168,383 | $1.1M | 0.2% | 0.8% | -74.1% |
| 20 | UBS Group AG | 130,052 | $886,955 | 0.0% | 0.6% | +166.5% |
| 21 | GOLDMAN SACHS GROUP INC | 128,008 | $873,015 | 0.0% | 0.6% | +103.6% |
| 22 | NORTHERN TRUST CORP | 127,316 | $868,295 | 0.0% | 0.6% | +1.9% |
| 23 | FMR LLC | 126,922 | $865,607 | 0.0% | 0.6% | +1367.1% |
| 24 | VANGUARD FIDUCIARY TRUST CO | 118,903 | $810,918 | 0.0% | 0.6% | +5.8% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 117,622 | $802,182 | 0.0% | 0.6% | +5.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.